Addressing Cardiotoxicity Risks in Long-term Use of Human Epidermal Growth Factor Receptor 2 Inhibitors  Internal Medicine. 2025;64(12):1784-1785
https://pubmed.ncbi.nlm.nih.gov/?otool=iaufhhslib&term=39428519

Artificial intelligence entering the pathology arena in oncology: current applications and future perspectives  Annals of Oncology. 2025;36(7):712-725
https://pubmed.ncbi.nlm.nih.gov/?otool=iaufhhslib&term=40307127

BMT-CARE App: A Randomized Controlled Trial of a Psychosocial Digital Application for Caregivers of Patients Undergoing Hematopoietic Stem-Cell Transplantation  Journal of Clinical Oncology. 2025;43(20):2265-2275
https://pubmed.ncbi.nlm.nih.gov/?otool=iaufhhslib&term=40444925

Brain metastasis organoids: A systematic review of their methods and clinical application  Journal of Clinical Neuroscience. 2025;138:111401
https://pubmed.ncbi.nlm.nih.gov/?otool=iaufhhslib&term=40532281

Digital twins in radiology: A systematic review of applications, challenges, and future perspectives  European Journal of Radiology. 2025;189:112166
https://pubmed.ncbi.nlm.nih.gov/?otool=iaufhhslib&term=40382804

Effectiveness and Safety of Bright Light Therapy in Oncological Patients: A Systematic Review  Journal of Pain and Symptom Management. 2025;70(1):e1-e24
https://pubmed.ncbi.nlm.nih.gov/?otool=iaufhhslib&term=40185343

Effectiveness of nursing interventions based on lung cancer trajectory: A systematic review and meta-analysis  International Nursing Review. 2025;72(3):e13074
https://pubmed.ncbi.nlm.nih.gov/?otool=iaufhhslib&term=39604008

Effects of sodium-glucose cotransporter 2 inhibitors in patients with cancer and diabetes mellitus: a systematic review and meta-analysis  Eur Heart J Cardiovasc Pharmacother. 2025;11(4):343-352
https://pubmed.ncbi.nlm.nih.gov/?otool=iaufhhslib&term=40274419

Extending Cancer Survival with Exercise - Time for Oncology to Act  New England Journal of Medicine. 2025;393(1):82-84
https://pubmed.ncbi.nlm.nih.gov/?otool=iaufhhslib&term=40601943

Intrapleural fibrinolytic therapy for loculated malignant pleural effusion: A systematic review and meta-analysis  Critical Reviews in Oncology/Hematology. 2025;211:104749
https://pubmed.ncbi.nlm.nih.gov/?otool=iaufhhslib&term=40294877

Lifestyle and Cancer Survival, the Best Time of Day for Treatment, and More-Highlights From ASCO  JAMA. 2025
https://pubmed.ncbi.nlm.nih.gov/?otool=iaufhhslib&term=40576984

Musings on the oncology floor  Journal of Hospital Medicine. 2025;20(7):808
https://pubmed.ncbi.nlm.nih.gov/?otool=iaufhhslib&term=39961780

Occurrence Rates of Delirium in Brain Tumor Patients: A Systematic Review and Meta-Analysis  Cancers. 2025;17(12)
https://pubmed.ncbi.nlm.nih.gov/?otool=iaufhhslib&term=40563648

Patient-centred care in precision oncology: A systematic review  Patient Education and Counseling. 2025;136:108753
https://pubmed.ncbi.nlm.nih.gov/?otool=iaufhhslib&term=40121935

Perioperative exercise and post-operative mortality in patients undergoing oncologic surgery: a systematic review and meta-analysis  Supportive Care in Cancer. 2025;33(7):558
https://pubmed.ncbi.nlm.nih.gov/?otool=iaufhhslib&term=40484889

Pharmacogenomics in pediatric oncology patients with solid tumors related to chemotherapy-induced toxicity: A systematic review  Critical Reviews in Oncology/Hematology. 2025;211:104720
https://pubmed.ncbi.nlm.nih.gov/?otool=iaufhhslib&term=40222694

PRODIGE 29-UCGI 26 (NEOPAN): A Phase III Randomized Trial Comparing Chemotherapy With FOLFIRINOX or Gemcitabine in Locally Advanced Pancreatic Carcinoma  Journal of Clinical Oncology. 2025;43(20):2255-2264
https://pubmed.ncbi.nlm.nih.gov/?otool=iaufhhslib&term=40378359

Prostate Cancer Outcomes in Immunocompromised Patients: A Systematic Review and Meta-analysis  Eur Urol Oncol. 2025
https://pubmed.ncbi.nlm.nih.gov/?otool=iaufhhslib&term=40533295

Relacorilant and nab-paclitaxel in patients with platinum-resistant ovarian cancer (ROSELLA): an open-label, randomised, controlled, phase 3 trial  Lancet. 2025;405(10496):2205-2216
https://pubmed.ncbi.nlm.nih.gov/?otool=iaufhhslib&term=40473448

Retifanlimab with carboplatin and paclitaxel for locally recurrent or metastatic squamous cell carcinoma of the anal canal (POD1UM-303/InterAACT-2): a global, phase 3 randomised controlled trial Lancet. 2025;405(10495):2144-2152
https://pubmed.ncbi.nlm.nih.gov/?otool=iaufhhslib&term=40517007

Sarcopenia in Children and Adolescents With Cancer: A Systematic Review of Diagnostic Assessment Methods  Pediatric Blood & Cancer. 2025:e31844
https://pubmed.ncbi.nlm.nih.gov/?otool=iaufhhslib&term=40515496

Shared decision-making interventions in neuro-oncology practice: a systematic review  Journal of Neuro-Oncology. 2025
https://pubmed.ncbi.nlm.nih.gov/?otool=iaufhhslib&term=40549119

Systematic literature review of intravenous versus subcutaneous administration of oncology therapies: A clinical, economic and patient perspective  Cancer Treatment Reviews. 2025;139:102974
https://pubmed.ncbi.nlm.nih.gov/?otool=iaufhhslib&term=40592035

Systematic review and meta-analysis of right ventricular changes in cancer-therapy - The forgotten ventricle in cardio-oncology  Current Problems in Cardiology. 2025;50(7):103039
https://pubmed.ncbi.nlm.nih.gov/?otool=iaufhhslib&term=40157515

Systematic review of the tools and outcomes for the assessment of acute radiation dermatitis severity  Clin Transl Radiat Oncol. 2025;53:100977
https://pubmed.ncbi.nlm.nih.gov/?otool=iaufhhslib&term=40502854